Search for: "Teva Pharmaceuticals"
Results 1281 - 1300
of 1,430
Sort by Relevance
|
Sort by Date
20 Oct 2008, 3:34 am
Teva Pharmaceutical Industries Ltd et al.1:08-cv-01071; filed October 14, 2008 in the Eastern District of VirginiaDeclaratory judgment of non-infringement, invalidity, and unenforceability of U.S. [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years (GenericsWeb) US:… [read post]
17 Oct 2008, 3:13 am
Biologicsland, brought to you by Teva Pharmaceuticals, is an on-line board game where you pick a person to act as your player, like politician or scientist (and why is the floor being sawed out from under the lobbyist?) [read post]
10 Oct 2008, 11:32 am
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) - US: Trial judge grants permanent injunction in case relating to recombinant erythropoietin (EPO) patent: Amgen v… [read post]
6 Oct 2008, 3:38 am
Teva Pharmaceuticals USA Inc.1:08-cv-00627; filed September 26, 2009 in the District Court of Delaware Infringement of U.S. [read post]
27 Sep 2008, 12:08 am
(Biotech Blog) United States: Patent for generating oxygen in a process that mimics photosynthesis (Competitive info) Products Adderall (Dextroamphetamine/Racemic DL-ampthetamine) - US: Judge denies Sandoz’ bid for summary judgment of non infringement in patent dispute with Shir eover Adderall (Law360) Carbatrol (Carbamazepine) - US: Judge refuses to grant summary judgment to Corepharma in patent dispute with Shire Laboratories over generic Carbatrol (Law360) Clarinex… [read post]
25 Sep 2008, 4:23 am
By Donald Zuhn -- Last week, Teva Pharmaceutical Industries Ltd. announced that the European Commission's Directorate General for Enterprise and Industry has granted the company a marketing authorization for its human granulocyte colony stimulating factor (G-CSF) product. [read post]
23 Sep 2008, 9:34 pm
FDA To Collaborate With Complaining Patients On Study Of Reported Problems With This Generic Version Of Antidepressant Wellbutrin XL (Posted by Tom Lamb at DrugInjuryWatch.com) By means of a September 23, 2008 Wall Street Journal (WSJ) article, "Wellbutrin Generic to Get New Review", we learned that the FDA is going to re-visit the issues of whether Budeprion XL -- which is made by Impax Laboratories Inc. and distributed by Teva Pharmaceutical Industries Ltd. -- is as… [read post]
19 Sep 2008, 6:00 pm
: (IP finance), United States: An open letter for the General Counsel of the PTO on your San Diego presentation next week: (Hal Wegner), United States: Cocoa genome: breaking intellectual property barriers: (Thomson Reuters Scientific), Vietnam: Patentability of second medical use claims in Vietnam is again questionable: (Trung Truc JSC) Pharma & Biotech - Products Allegra (Fexofenadine) - Canada: Motion for summary judgment of noninfringement dismissed in patent infringement… [read post]
19 Sep 2008, 4:54 am
The 20-page report, entitled "Stimulating Innovation in the Biologics Industry: A Balanced Approach to Marketing Exclusivity," was funded by Teva Pharmaceuticals USA (see Teva press release). [read post]
13 Sep 2008, 4:35 am
• Teva Pharmaceutical Industries Inc. spent $490,000... [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46) Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont sign up… [read post]
8 Sep 2008, 4:36 am
Teva Pharmaceutical... [read post]
29 Aug 2008, 1:25 pm
: (IP finance), Facebook removes international access to Scrabulous, except from India: (Ars Technica), (Techdirt), Reverse engineering can resolve conflict between standardisation and competition: (Techdirt), Benefits of piracy aren’t always in the expected places: (Techdirt) Events 1-3 September: Federation of Indian Chambers of Commerce and Industry, Department of Industrial Property and Promotion, and WIPO conference on ‘Development and IP: Building synergies… [read post]
25 Aug 2008, 4:10 am
., Teva Pharmaceuticals USA, Inc. v. [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events 26 August:… [read post]
21 Aug 2008, 9:43 pm
Following the Federal Circuit's decision in Teva Pharmaceuticals USA, Inc. v. [read post]
19 Aug 2008, 11:07 am
``It didn't take an extraordinarily long amount of conversation before he said, `Yeah, I want to do something on this,''' said Barrett, now vice president of government affairs in Washington for generic-drug maker Teva Pharmaceutical Industries Ltd. of Petah Tikva, Israel.A narrower version of the measure, allowing quicker access to generics in certain circumstances, eventually passed. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
14 Aug 2008, 4:56 am
.), elicited dozens of responses, from innovator and generic pharmaceutical companies (including Amgen and Biogen Idec on one hand and Teva Pharmaceutical and Mylan Labs on the other); industry groups like the Biotechnology Industrial Organization (BIO) and the Generic Pharmaceutical Association (GPhA); benefits... [read post]
